Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations.
Silverberg DS, Wexler D, Blum M, Keren G, Sheps D, Leibovitch E, Brosh D, Laniado S, Schwartz D, Yachnin T, Shapira I, Gavish D, Baruch R, Koifman B, Kaplan C, Steinbruch S, Iaina A. Silverberg DS, et al. Among authors: baruch r. J Am Coll Cardiol. 2000 Jun;35(7):1737-44. doi: 10.1016/s0735-1097(00)00613-6. J Am Coll Cardiol. 2000. PMID: 10841219 Free article.
The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study.
Silverberg DS, Wexler D, Sheps D, Blum M, Keren G, Baruch R, Schwartz D, Yachnin T, Steinbruch S, Shapira I, Laniado S, Iaina A. Silverberg DS, et al. Among authors: baruch r. J Am Coll Cardiol. 2001 Jun 1;37(7):1775-80. doi: 10.1016/s0735-1097(01)01248-7. J Am Coll Cardiol. 2001. PMID: 11401110 Free article. Clinical Trial.
The correction of anemia in severe resistant heart failure with erythropoietin and intravenous iron prevents the progression of both the heart and the renal failure and markedly reduces hospitalization.
Silverberg DS, Wexler D, Blum M, Tchebiner J, Sheps D, Keren G, Schwartz D, Baruch R, Yachnin T, Shaked M, Zubkov A, Steinbruch S, Iaina A. Silverberg DS, et al. Among authors: baruch r. Clin Nephrol. 2002 Jul;58 Suppl 1:S37-45. Clin Nephrol. 2002. PMID: 12227725
Normal-range albuminuria in healthy subjects increases over time in association with hypertension and metabolic outcomes.
Grupper A, Schwartz D, Berliner S, Shashar M, Grupper A, Baruch R, Schwartz IF, Weinstein T, Ben-Bassat OK, Rogowski O, Zeltser D, Shapira I, Shenhar-Tsarfaty S. Grupper A, et al. Among authors: baruch r. J Am Soc Hypertens. 2018 Nov;12(11):759-767. doi: 10.1016/j.jash.2018.08.003. Epub 2018 Aug 23. J Am Soc Hypertens. 2018. PMID: 30219648
73 results